Navigation Links
Axiom Accelerated Patient Recruitment Rolls Out
Date:9/28/2009

ategies that Axiom offers in support of Top 20 pharmaceutical companies, clinical research organizations and healthcare organizations.

"Clinical studies are an important way to advance research. In an era when healthcare is one of the nation's leading topics of conversation, we believe clinical studies should be accessible to as many people as possible," continued Julie Oimoen, Project Manager at Axiom. "We can best accomplish this by allowing potential participants to respond by using the medium with which they're most comfortable. For many candidates in today's world, that means text messaging."

Axiom is able to identify pre-qualified audiences for numerous ailments and diseases ranging from asthma to adolescent schizophrenia. Text messages can be used to directly communicate with these pre-qualified audiences to gauge interest in participating in a clinical study that may help minimize symptoms or treat the disease. These services can also retain participants through support services like appointment reminders and treatment instructions. Text messaging provides a convenient, direct way to get in touch with pre-qualified potential patients quickly and efficiently.

To learn more about Axiom Accelerated Patient Recruitment and how text messaging supports recruitment efforts for clinical research studies, please text STUDY to 77411 . . . visit http://www.recruitpatients.com . . . or call (888) 859-4656.

###

Read the full story at http://www.prweb.com/releases/Axiom_Text/Medical_Research/prweb2946094.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2

Related medicine news :

1. AXIOM Selects Foresight Corp. for Integration Partnership
2. Axiom Named to Healthcare Informatics Top 100 List
3. Axiom Consulting Partners Announces the Results of its Return On Sales Investment Survey
4. Global Decompression Announces C.O.D. Available on All Used Axiom DRX 9000 Spinal Decompression Systems
5. WorldatWork Publishes Axiom Consulting Partners' Article on ‘Planning for the New Normal', an Alternative Approach to Compensation Planning
6. Axiom Worldwide Convicted of Infringing a Hako-Med Patent
7. This Holiday Season Some Dream of a White Christmas - The Accelerated Cure Project Dreams of Developing a Cure for Multiple Sclerosis
8. Accelerated head growth can predict autism before behavioral symptoms start
9. Adult stem cell changes underlie rare genetic disease associated with accelerated aging
10. DuPont Chief Financial Officer Reviews Companys Accelerated Growth Plan
11. American Stock Exchange Lists Merrill Lynchs Accelerated Return Notes Linked to the Amex Health Care Select Sector Index
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Axiom Accelerated Patient Recruitment Rolls Out 
(Date:7/6/2015)... CA (PRWEB) , ... July 06, 2015 , ... On June 22, 2015, Fox News in a report titled “ ... the time they turn age 35 a quarter of all women in the U.S. will suffer ... loss is stigmatized and rarely discussed. One woman, a former beauty queen, who was ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Asian-Pacific market for rheumatoid ... is expected to grow at a CAGR of over 3.2 percent in the years ... is likely to be mainly spurred by an anticipated launch of a number of ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope ... patients, caregivers and medical professionals to chat with the CHN patient services team ... “Receiving a cancer diagnosis is often the most traumatic experience of a person’s ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... In a ... learn how to reduce their risk of having a fracture through the bone health ... Fractures Awareness Day. , “We are participating because our residents need this information to ...
(Date:7/6/2015)... Florida (PRWEB) , ... July 06, 2015 , ... ... solutions, announced today that Randstad Technologies selected Aspect Software Unified IP contact center ... the United States, selected Aspect Unified IP as its future call center platform. ...
Breaking Medicine News(10 mins):Health News:The Stigma of Female Hair Loss and Hair Restoration Solutions 2Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:National Bone Health Screening and Awareness Day 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 2Health News:Aspect Software Unified IP, Hosted by Promero, Selected by Randstad Technologies 3
... Should men over a certain age be treated for prostate ... result in significant side effects if they may not live ... UCLA,s Jonsson Comprehensive Cancer Center has shown that men over ... a single comorbid condition such as peripheral vascular disease or ...
... (HealthDay News) -- Diabetes patients who visit a primary ... their blood glucose, blood pressure and cholesterol levels, researchers ... risk of diabetes-related complications, but most diabetes patients do ... do not outline how often diabetes patients should see ...
... Sept. 26, 2011 A large-scale data review ... over the last decade showed the endoscopic procedure to ... the small intestine. DBE had a pooled detection rate ... mid-gastrointestinal bleeding was found to be the most common ...
... patients who use a new combination of the chemotherapy, ... before surgery have an 88 percent chance of surviving ... trial presented at the plenary session, October 3, 2011, ... for Radiation Oncology (ASTRO). "The results of the ...
... Tampa, Fla. (Sept, 26 2011) Researchers in Japan have ... canine teeth and dental pulp can be grafted and produce ... in the current issue of Cell Transplantation ... defects can occur for a number of reasons, and autogenous ...
... 26 (HealthDay News) -- Heart attack patients who take ... drugs such as aspirin or Plavix have a higher ... only, a new study finds. Commonly prescribed SSRIs ... prevent blood cells from sticking together and forming a ...
Cached Medicine News:Health News:Elderly patients may be undertreated for prostate cancer 2Health News:Elderly patients may be undertreated for prostate cancer 3Health News:More Frequent Doctor Visits May Benefit Diabetes Patients 2Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 2Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 3Health News:Study examining large-scale data of double balloon enteroscopy shows it is safe and effective 4Health News:Chemo plus radiation before surgery increases tumor response for rectal cancer 2Health News:Cell Transplantation study shows bone growth from implanted tooth and dental pulp stem cells 2Health News:Certain Antidepressants With Blood Thinners May Pose Risk for Heart Patients 2
(Date:7/6/2015)... BOSTON , July 6, 2015 ... Inc. (NASDAQ: ISIS ), announced today that ... Orphan Drug Designation to volanesorsen (ISIS-APOCIII Rx ) ... Syndrome (FCS).  FCS is a rare genetic disease ... of pancreatitis. In a Phase 2 study published ...
(Date:7/5/2015)... 6, 2015 Nihon University is pleased ... on Medical-Engineering Collaboration "Medicine Definitely Jumps Up with ... in Tokyo, Japan . Many ... research will present their achievements and future prospects ... industry produced with 8K technology. (Documentation: ...
(Date:7/3/2015)... 4, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... l,intermédiaire de plateformes éducatives gratuites et d,une conférence ... (Photo: http://photos.prnewswire.com/prnh/20150630/227090 ) , ... en ligne , Prendre en charge l,hypertension ...
Breaking Medicine Technology:Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 2Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 3Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 4Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 5Akcea Therapeutics Receives Orphan Drug Designation from the US FDA for Volanesorsen (ISIS-APOCIII Rx) for the Treatment of Familial Chylomicronemia Syndrome 6Nihon University to Host International Symposium on Medical-Engineering Collaboration 2Nihon University to Host International Symposium on Medical-Engineering Collaboration 3Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Asie centrale et du Sud-Est grâce à la formation médicale 3
... 23, 2007 -,Gentium S.p.A. (NASDAQ: GENT) (the ... will be the subject of a poster,presentation ... being held in,Rio de Janeiro, Brazil from ... 2007, Cinara Echart, Ph.D., Manager of,Biological Research ...
... 24 /CNW/ - The weight loss medication Xenical,(orlistat ... such as blood pressure, glycaemic,control and lipid profile ... and hypertension, according to a study analysis,presented at ... ,This analysis strengthens the wealth of data already ...
Cached Medicine Technology:Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 2Gentium's Defibrotide Highlighted in Poster Presentation at World,Congress of Nephrology 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 2New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 3New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 4New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 5New Data Show Xenical Significantly Reduces Cardiovascular Risk and,More Than Doubles Weight Loss Achieved in Overweight and Obese,People 6
Inquire...
Superior imaging through a 410,000 pixel CCD, unseen color replication from a digital signal processor in the scope, and the added benefit of four way tip deflection make the TF410 a superior choice ...
The computer-optimized optical design produces large, brilliant images of high resolution....
ACMI™ Distortion-Free Laparoscopes utilize technical advances in optical lens design to provide images without the fish-eye effect typically found on the peripheral viewing edges of conventional...
Medicine Products: